Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
A Phase I/II Trial of a Conditionally Replication-Competent Adenovirus (Delta-24-RGD) Administered by Convection Enhanced Delivery in Patients with Recurrent Glioblastoma Multiforme.

Proposed period of release:
01/01/2010 to 01/01/2013

Name of the Institute(s) or Company(ies)
VU Medical Center, Department of medical oncology
De Boelelaan 1117, 1007 MB A’dam - The Netherlands;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Genus: Mastadenovirus
Species: human adenovirus

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Human adenovirus type 5Mastadenovirushuman adenovirussubgroup Chuman serotype 5

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known